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Abstract
Background: Degenerative suspensory ligament desmitis (DSLD) is a debilitating disorder thought to be
limited to suspensory ligaments of Peruvian Pasos, Peruvian Paso crosses, Arabians, American Saddlebreds,
American Quarter Horses, Thoroughbreds, and some European breeds. It frequently leads to persistent,
incurable lameness and need to euthanize affected horses. The pathogenesis remains unclear, though the
disease appears to run in families. Treatment and prevention are empirical and supportive, and not
effective in halting the progression of the disease. Presently, the presumptive diagnosis of DSLD is obtained
from patient signalment and history, clinical examination, and ultrasonographic examination of clinically
affected horses, and is confirmed at post mortem examination. Presently, there are no reliable methods
of diagnosing DSLD in asymptomatic horses. The goal of this study was to characterize and define the
disorder in terms of tissue involvement at the macroscopic and microscopic levels.
Results: We examined tissues and organs from 28 affected horses (22 Peruvian Pasos, 6 horses of other
breeds) and from 8 control horses. Histopathological examination revealed the presence of excessive
amounts of proteoglycans in the following tissues removed from DSLD-affected horses: suspensory
ligaments, superficial and deep digital flexor tendons, patellar and nuchal ligaments, cardiovascular system,
and sclerae. Electron microscopy demonstrated changes in diameters of collagen fibrils in the tendon, and
in smooth muscle cells of the media of the aorta compatible with increased cell permeability in DSLD-
affected cells. Separation of tendon extracts by gel chromatography revealed the presence of additional
proteoglycan(s) in extracts from affected, but not control extracts.
Conclusion: This study demonstrates for the first time that DSLD, a disease process previously thought
to be limited to the suspensory ligaments of the distal limbs of affected horses, is in fact a systemic disorder
involving tissues and organs with significant connective tissue component. Abnormal accumulation of
proteoglycans between collagen and elastic fibers rather than specific collagen fibril abnormalities is the
most prominent histological feature of DSLD. Because of this observation and because of the involvement
of many other tendons and ligaments beside the suspensory ligament, and of non-ligamentous tissue we,
therefore, propose that equine systemic proteoglycan accumulation or ESPA rather than DSLD is a more
appropriate name for this condition.
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Background
Injuries to tendons and ligaments are significant causes of
lameness and financial losses in the equine industry. They
account for nearly a third of all equine injuries that occur
during racing, with a reported incidence of 8–43% [1-4].
These tissues heal extremely slowly and the repaired tissue
is inferior in elasticity and strength as compared to the
original tissue, predisposing to recurrence and repeated
injury in up to 80% of affected horses [5-8]. Tendon and
ligament injuries may occur as result of acute overloading
of the tendon or ligament or secondary to idiopathic
degenerative changes [9-11].
Degenerative suspensory ligament desmitis (DSLD) is a
heritable, debilitating syndrome recognized in Peruvian
Pasos, Peruvian Paso crosses, Arabians, American Saddle-
breds, American Quarter Horses, Thoroughbreds, and
some European breeds [12]. Affected Peruvian Paso
horses demonstrate clinical signs at an earlier age than
horses of other breeds [13]. Horses with DSLD typically
develop an insidious onset of bilateral or quadrilateral
lameness without a history of trauma or performance
related injury [13]. Ultrasonography of affected ligaments
is characterized by a diffuse loss of echogenicity and an
irregular fiber pattern [14-16]. Unique to DSLD, however,
is diffuse enlargement of the affected ligaments despite
exercise restrictions [12,13]. The pathogenesis of DSLD is
incompletely understood. DSLD has been observed to fol-
low familial lines; however, a definitive heritable mecha-
nism has not been established. The presumptive diagnosis
of DSLD is obtained from patient signalment and history,
clinical examination, and ultrasonographic examination
of clinically affected horses, and it is confirmed only at
post mortem examination. Presently, there are no reliable
methods of diagnosing DSLD in asymptomatic horses.
Though DSLD has been believed to be a disorder confined
to the suspensory ligaments (SLs) of the distal limbs of
horses, the mechanism of this disease remains largely
unknown. The objectives of this study were to 1) identify
whether tissues other than SLs are affected by DSLD and
2) characterize the pathology present in such tissues. This
study was initiated because pilot findings from our labo-
ratory suggested that the abnormalities in the collagenous
Table 1: Peruvian Paso horses affected with DSLD
age, sex onset  of  
symptoms
clinical family 
affected
legs patella heart PA aorta eyes other tissues ultrasound
1 1 y, M 6 mos four sire 4 mod ND cor + ND + both+ nuchal+ 2/2 front SLs
2 1 y, F 6 mos four sire 4 mild ND cor + ND + - nuchal, lung + 2/2 front SLs
3 18 mo M 6 mos four parents 4 mild ND ND ND ND ND nuchal+ ND
4 18 mo M 6 mos four parents 4 mod ND ND ND ND ND nuchal+ ND
5 1.5 y, M at 1 y four dam 4 mild + - + - both+ lung + 4 SLs
6 2 y, F birth four sire 4 mod ND ND ND + ND ND ¾ SLs
7 3 y, F 6 mos rear parents 4 mild + cor + ND + both + nuchal, lung + 4 SLs
8 3 y, M 1 year front legs no 4 severe ND cor + ND + ND nuchal+ ND
9 7 y, F years four dam 4 severe ND valve+ + + ND lung + 2/4 SLs
10 8 y, M years four sire, foals 1 SL exam, 
mod*
ND ND ND ND L eye + nuchal+ 4 SLs
11 9 y, F at 9 y rear dam 4 severe ND valve+ + + ND lung + 4 SLs
12 9 y, M at 6 y four no 4 mild + cor + + + both+ - 4 SLs
13 9 y, M years fallen 
crest, legs
dam 4 mild ND cor + ND - both + nuchal, lung + ND
14 11 y, F years four no 1 SL exam, 
mild*
ND ND ND ND R eye + nuchal+ 2/2 hind SLs
15 15 y, F years four no 4 mod ND ND ND + ND ND 4 SLs
16 15 y, F years front foal 4 mod + cor + PA+ + both + nuchal+ ND
17 15 y, F years four sire, son 4 mod ND cor + ND + both + nuchal, 
shoulder+
ND
18 18 y, F years four no 1 leg exam, 
severe*
ND ND ND ND ND ND 4 SLs
19 18 y, F years rear legs foals 4 mild ND ND ND - R eye + nuchal, lung + 4 SLs
20 21 y, M late onset four no 4 mod + cor + - - R eye + - 4 SLs
21 21 y, M years legs no 4 severe ND cor + ND + R eye + lung + 4 SLs
22 unknown unknown unknown no 4 mild ND - ND - ND - ND
Age: age at necropsy; ND: not done; legs: SDFT, DDFT and SL; cor: coronary artery; PA: pulmonary artery; nuchal: nuchal ligament
Mild, mod (moderate), severe: describes the average severity of pathology in examined leg tendons and ligaments; +: accumulation of proteoglycans 
in other tissues; -: no proteoglycan accumulation
*only limited tissue was available for examinationBMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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tissue of affected horses are not confined to the SLs distal
limbs, but may be manifested systemically, in virtually all
collagen containing tissues. In this preliminary work
abnormal accumulations of yet to be identified proteogly-
cans appeared to be present not only in the SL, but also in
the superficial and deep digital flexor tendons (SDFT and
DDFT, respectively), patellar and nuchal ligaments, aorta,
coronary arteries and sclerae of DSLD-affected horses.
Results
Harvested tissues
Twenty eight horses were referred because of clinical diag-
nosis of DSLD supported by known bilateral (n = 9) or
quadrilateral (n = 17) lameness (the lameness status was
not noted in two horses). Lameness was accompanied by
an excessively dropped fetlock appearance, and/or palpa-
ble enlargement of the branches or body of the suspen-
sory ligament. Ultrasound performed on 19 horses
showed evidence of suspensory ligament enlargement
with changes in echogenicity, e.g., a hypoechoic, irregular
fiber ligament disruption, in at least 14 horses (full ultra-
sound descriptions were not available in all cases) accom-
panied by intra-ligamentous calcification in 3 cases. At
least 16 horses had known family history of DSLD (Tables
1 and 2). The 28 horses included 22 Peruvian Paso horses
(Table 1) and 6 horses of other breeds (2 thoroughbreds,
1 Arab, 1 Hanovarian, 1 Appaloosa and 1 quarter horse,
Table 2). In 25 affected horses SDFTs, DDFTs and SLs
from all 4 extremities were examined grossly and micro-
scopically at their proximal and midmetacarpal regions;
SDFT, DDFT and SL from only one extremity were exam-
ined in the remaining three animals. One section from the
proximal end and another section from the midmetacar-
pal end of a tendon or ligament were taken for histologi-
Table 3: Control horses
age, sex, breed onset of 
symptoms
clinical family 
affected
legs patella heart PA aorta eyes other 
tissues
ultrasound
1 young, F, quarter NA healthy no 2 fibr. 
tendons, 
mild
ND - ND - ND ND ND
2 5 mo, M, Percheron NA healthy no foci in 4 legs ND - ND - - nuchal+ ND
3 6 y, F, quarter NA Cushing no fibrosis in 
four, mild
- - ND - - lung + ND
4 8 y, F, quarter NA healthy no foci in 4 legs - - ND - - - ND
5 8 y, M, Tennessee 
walking
NA slight 
fever
no fibrosis in 
four, mild
- - ND - - nuchal+ ND
6 9 y, F, Arab NA healthy no foci in 4 legs - - ND - - nuchal+ ND
7 9 y, F, Per Paso NA healthy no four, mild + cor + ND - - nuchal, 
lung +
ND
8 10 y, M, pony NA healthy no foci in 4 legs - cor + ND - - nuchal, 
lung +
ND
Age: age at necropsy; ND: not done; legs: SDFT, DDFT and SL; cor: coronary artery; PA: pulmonary artery; nuchal: nuchal ligament
Mild, mod (moderate), severe: describes the average severity of pathology in examined leg tendons and ligaments; +: accumulation of proteoglycans 
in other tissues; -: no proteoglycan accumulation
Table 2: DSLD-affected horses of other breeds
age, sex, breed onset of 
symptoms
clinical family 
affected
legs patella heart PA aorta eyes other 
tissues
ultrasound
1 18 mo, F thoro 6 mos rear legs no 4 mild ND ND ND + ND nuchal+ ND
2 5 y, M Han 16 mo forelimbs no 4 severe ND Cor + ND + R eye + nuchal+ front SLs
3 5 y, F, Appal 6 mos four sire 4 severe yes cor N ND + both+ nuchal, 
lung +
2/2 hind SLs
4 8 y, M thoro 6 yr rear legs sire sudden 
death
4 mild ND ND ND + - nuchal+ rear legs
5 16 y, M, Arab unknown years no 4 mild ND valve+ ND + - - ND
6 18 y, F quarter, unknown rear legs, 
lung sounds
no 4 mild ND cor ND + both+ nuchal, 
lung +
rear legs
Age: age at necropsy; ND: not done; legs: SDFT, DDFT and SL; cor: coronary artery; PA: pulmonary artery; nuchal: nuchal ligament; Han: 
Hanovarian; Appal: Appaloosa; thoro: thoroughbred
Mild, mod (moderate), severe: describes the average severity of pathology in examined leg tendons and ligaments; +: accumulation of proteoglycans 
in other tissues; -: no proteoglycan accumulationBMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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Comparison of normal and DSLD-affected tendons Figure 1
Comparison of normal and DSLD-affected tendons. A. Only thin septa (*) separate bundles of collagen and elastic fibers 
in a normal tendon. Hematoxylin & eosin, magnification × 200. B. A section of DSLD-affected tendon reveals PG deposits (*) 
between collagen fibers and in septa. Hematoxylin & eosin, magnification × 200. C. A section of tendon from a horse without 
DSLD shows the presence of fibrosis or scar tissue (*) between collagen fibers and in septa. Hematoxylin & eosin, magnifica-
tion × 200. D. A proliferative lesion found in one DSLD case consists of swirls of active fibroblasts in young, well vascularized 
tissue. Hematoxylin & eosin, magnification × 200.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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cal examination. The following tissues were collected
from most horses: eyes, portions of nuchal ligament, one
of the patellar ligaments, portions of the cardiovascular
system, lung, skin, muscle and kidney.
In addition, tissues from 8 control horses of both sexes,
different breeds (3 quarter horses, 1 Percheron, 1 Arab, 1
Tennessee walking, 1 pony and 1 Peruvian Paso) and ages
and with no known medical problems (Table 3) were
examined as well.
Pathology of tendons and ligaments
Normal tendons and ligaments have a uniform, grayish
pink color and are pliable on palpation. In normal ten-
dons and ligaments fascicles and bundles of collagen fib-
ers are separated by thin endotenon septa that contain
only a few small blood vessels in SDFTs and DDFTs, and
in patellar and nuchal ligaments (Figure 1A). In addition,
small islands of striatus muscle are interspersed with bun-
dles of collagen fibers of the suspensory ligaments; a
reminder of the evolutionary past when SL was more a
muscle rather than a ligament (or tendon strictly speak-
ing).
All SDFTs, DDFTs and SLs were found to be affected in all
four extremities in 25 DSLD horses and the one extremity
that was examined in the 3 remaining DSLD horses (no.
10, 14 and 18, Table 1). Usually but not always both prox-
imal and midmetacarpal portions of the tendons and lig-
aments were affected. Grossly the affected tendons and
suspensory ligaments felt firm and inflexible, and con-
tained foci of white tissue. The histopathological findings
consisted of deposits of acellular amorphous material
staining blue with hematoxylin & eosin stain between col-
lagen fibers, in septa and around blood vessels (Figure
1B). In some cases the septa were also infiltrated with
small blood vessels. In many tendons and ligaments the
diffusely distributed proteoglycans gave the collagen a dif-
fuse blue tinge. The extracellular matrix of affected septa
and blood vessels stained for decorin, biglycan and aggre-
can. Small foci of cartilage or calcifications were occasion-
ally dispersed among collagen fibers. The cytoplasm of
chondrocytes forming these foci stained strongly for big-
lycan and aggrecan, considerably less for decorin (Figure
2). No immunostaining was noted in the extracellular
matrix of the cartilage.
In addition, rear suspensory ligaments in one DSLD horse
(case no. 6, Table 2) revealed the presence of exuberant
cellular areas consisting of fibroblasts in young connective
tissue, with very little collagen present but with incipient
PG accumulation (Figure 1D). Hypercellular septa due to
proliferation of fibroblasts and increased number of
blood vessels together with mild deposits of PGs were
observed in a young Peruvian Paso (1.5 yr old male, case
Immunostaining of metaplastic cartilage Figure 2
Immunostaining of metaplastic cartilage. A. Immunos-
taining reveals very little decorin, magnification × 500. B. The 
cartilage reveals the presence of aggrecan (Ј) in the cyto-
plasm, magnification × 400. C. The same chondrocytes were 
also positive for biglycan (Ј), magnification × 400. Coun-
testain: hematoxylin.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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no. 5, Table 1). In one horse (no. 5, Table 2) actively pro-
liferating synovium containing numerous blood vessels
was observed in the midmetacarpal portion of the left rear
suspensory ligament (data not shown). By light micros-
copy there was complete absence of inflammatory cells in
all types of lesions, including the exuberant proliferating
foci.
The histopathological changes in leg tendons and SLs
were divided into mild, moderate and severe as indicated
in Tables 1, 2. Because so many tendons were evaluated
the grading represents an overall degree of severity of dis-
ease for each animal. It was based on the worst lesions
present in several tendons and SLs in extremities from the
same animal. Nine cases were quantified as mild (based
on up to 10% of tissue affected by lesions), 8 as moderate
(i.e., up to 30% of tissue affected by lesions) and 5 as
severe (i.e., more than 30% of tissue affected by lesions).
It is interesting that there was little correlation between
the severity of the lesions and signalment or clinical his-
tory, such as pain or lameness (data not shown).
Similar histopathological changes, i.e., either focal depos-
its of PGs or areas of diffuse blue tinge, were present in all
examined patellar (6 horses) and majority of nuchal liga-
ments (17/19 examined samples, Figure 3B) from DSLD
horses. Figure 3D demonstrates that this material gave a
strong reaction with alcian blue, indicating that it consists
of proteoglycans (PGs).
Interestingly, histological signs of old tendon injuries
were found in all examined control horses in at least one
tendon (or suspensory ligament), and in all four extremi-
ties in 5 horses (Table 3). Unlike the DSLD tendons and
suspensory ligaments, these tendons and SLs containing
lesions, however, were pliable on palpation and no gross
lesions were apparent. Histologically, the injury was char-
acterized by the presence of fibrosis accompanied by focal
accumulation of proteoglycan material most commonly
in the midmetacarpal portion of the tendon or suspensory
ligament (Figure 1C). The lesions were less extensive than
the lesions in the DSLD tendons and were either mild or
just consisted of small foci (Table 3). One horse, a 9 year
old Peruvian Paso, exhibited histopathological changes in
tendons of all 4 extremities, the nuchal ligament and
other tissues consistent with DSLD (horse no. 7, Table 3).
Nuchal ligaments from four control horses revealed the
presence of small foci of PGs. In general, the foci were
much smaller than the PG deposits found in DSLD liga-
ments and were limited to only a small area of the nuchal
ligament. Another control horse (no. 7, Table 3) showed
more extensive changes in the nuchal ligament and other
tissues consistent with diagnosis of DSLD (see above).
Electron microscopic changes in DSLD-affected tendons
Cross-sections from midmetacarpal portions of SDFTs
were examined. The majority of collagen fibrils in normal
tendon had a bimodal distribution, most fibrils having a
fairly large diameter. Only a few fibrils with small diame-
ter were observed (Figure 4A). Sections from DSLD-
affected tendon showed a marked increase in the number
of mostly small fibrils dispersed among larger fibrils (Fig-
ure 4B).
Sepharose CL-2B chromatography of tendon 
proteoglycans
We performed an initial analysis of proteoglycan compo-
sition in the midmetacarpal portion of the SDFT. Because
this analysis is time and labor intensive, it was done only
on a limited number of samples. All Sepharose CL-2B
chromatographs from one control (no. 1, Table 3) and
two affected horses (no. 4 and 8, Table 1) showed separa-
tion into one main peak (Figure 5). Sodium dodecyl sul-
fate polyacrylamide gel electrophoresis (SDS-PAGE) on
fractions pooled from the main peak from the extract
from DSLD tendons showed a distinct band at ~180 kDa
(Figure 6, arrowhead). The presence of the band seen only
in abnormal tendons was independent of treatment with
chondroitinase ABC. Treatment with chondroitinase ABC
led to the appearance of an 80 kDa band in the DSLD
sample (Figure 6, arrow). Interestingly, the control sample
revealed a band in the same location. Again the presence
of the band was independent of treatment with chondroi-
tinase ABC.
Changes in other tissues and organs
Focal deposits of proteoglycans were found in several
other collagen containing tissues in DSLD affected horses,
such as the aorta, pulmonary and coronary arteries and
sclera. No tissues besides tendons and ligaments (see
above) contained exuberant cellular connective tissue.
The walls of affected blood vessels showed irregular thick-
ening of the intima and media due to the presence of pro-
teoglycans (Figure 7B and 7F). This was accompanied by
collagen and elastic fiber bundle disorganization that was
due to separation of fibers by small pools of proteoglycans
staining strongly with alcian blue (Figure 7D and 7H).
Three examined heart valves from DSLD-affected horses
were vascularized. One examined control heart valve was
normal (data not shown). Transmission electron micros-
copy revealed the presence of numerous small vacuoles in
the cytoplasm of smooth muscle cells in media from
DSLD aorta (Figure 8B). The cell membrane of these cells
was thinner and discontinuous (Figure 8D). However, the
collagen fibrils and elastic fibers exhibited similar features
and appeared to be intact in normal and DSLD aortas Fig-
ure 8E and 8F).BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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Unilateral or bilateral scleral involvement was observed in
12/18 of DSLD horses where eyes were examined. The
changes consisted of blue discoloration of collagen fibers
(data not shown).
In 10 DSLD horses (out of 19 examined) varying in age
from 1 to 21 years, and in 3 out of the 7 examined control
horses minor lung lesions were present consisting of mild
peribronchial, perivascular and septal fibrosis (data not
shown). A small collection of mostly chronic inflamma-
tory cells were observed in the peribronchial fibrous tissue
of the older, but not of the younger horses (1, 1.5 and 3
years of age). In addition, the fibrosis was more promi-
nent in these 3 young horses, particularly around small
arteries. In one young horse (no. 2) small deposits of PGs
were discernible in alveolar walls.
Kidney, skeletal muscle and skin appeared normal in all
horses. Only one DSLD horse (no. 5, Table 2) was diag-
nosed as having chronic idiopathic granulomatous der-
matitis, panniculitis and rhabdomyositis in addition to
DSLD.
None of the control horses revealed systemic involvement
except for a 9 year old Peruvian Pasofino mare (no.7,
Table 3). The pathology in this horse was consistent with
DSLD (see above).
Histopathological changes in nuchal ligament Figure 3
Histopathological changes in nuchal ligament. A. Only thin septa separate bundles of collagen and elastic fibers in a nor-
mal nuchal ligament. Hematoxylin & eosin, magnification × 200 (× 200). B. In DSLD – affected tissue streaks of proteoglycans 
(Ј) separate bundles of collagen and elastic fibers. Hematoxylin & eosin, magnification × 200. C. Alcian blue stains very lightly 
normal nuchal ligament, magnification × 200. D. PGs accumulated among bundles stain intensively with alcian blue (Ј) in 
DSLD-affected nuchal ligament.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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Discussion
Historically, the pathology associated with the clinical
syndrome DSLD has been thought to be limited to the
suspensory ligaments of the distal limb of horses. The
findings of this study suggest that DSLD is in fact a sys-
temic disorder involving many tissues and organs with a
significant connective tissue component. Tissues with his-
tological lesions in addition to the suspensory ligament
documented in this study include deep and superficial
digital flexor tendons, patellar ligaments, aorta, coronary
arteries, nuchal ligaments, and ocular sclerae. In light of
these observations, a more appropriate term for this dis-
ease process may be equine systemic proteoglycan accu-
mulation (ESPA).
While specific collagen fibril abnormalities have been
reported to be a consistent feature of DSLD [13], our
observations suggest that abnormal accumulations of pro-
teoglycan between collagen fibers, within the tendon
matrix, and between elastic fibers in the blood vessels are
the most consistent and prominent histological feature
associated with DSLD affected horses rather than primary
collagen fibril abnormalities.
The staining properties of material accumulated in con-
nective tissues, the presence of cartilage metaplasia and
the appearance of an 80 kDa band after chondroitinase
ABC treatment in gel chromatography-separated tendon
extracts indicate that DSLD is indeed due to deposits of a
yet to be identified PG(s). The difference in immunostain-
ing for PGs between septa and blood vessels on one hand
and newly formed cartilage on the other (i.e., extracellular
vs cytoplasmic pattern of staining) can be attributed to the
fact that the cartilage foci were small and cellular, with
only relatively small amounts of extracellular matrix. In
other words the cartilage foci were young and thus in the
process of formation of extracellular matrix. It is likely
that the extracellular presence of PGs in the septa within
the tendon indicates long standing lesions. Because of
technical difficulties we did not attempt to "uncover anti-
gens" during the immunostaining procedure (that process
leads to the tendon sections slipping off the slide), and it
is possible that the immunostaining was incomplete.
We interpret the appearance of the 80 kDa band after
chondroitinase ABC treatment a result of digestion of
GAGs attached to a PG(s) of higher Mr (likely around 100
kDa). It is likely that the carbohydrate component is
chondroitin or dermatan sulfate [17]. Further studies are
in progress to identify this and the 180 kDa band which
appears only in the DSLD samples. The marked increase
in small collagen fibrils in DSLD tendons is most likely
secondary to qualitative changes in the synthesis of PG(s).
PGs are involved in regulation of collagen fibrillogenesis,
including the rate of formation and final sizes of fibrils
[18]. For example, decorin, the most common PG in the
tendon, limits collagen fibril growth, and, thereby, directs
tendon remodeling in response to tensile forces. It has
been shown that knock-out mice deficient in decorin have
fragile connective tissues [19]. Similarly, the absence of
biglycan and/or fibromodulin, two proteoglycans related
to decorin, in knock-out mice prevented formation of
mature collagen fibrils and led to ossification of tendon
fibrocartilage [20]. Whether the accumulated proteogly-
can(s) in DSLD is identical to any of these PGs remains to
be determined.
The proliferative tendon lesions found in three horses
with DSLD are significant as they represent in all likeli-
hood early lesions which eventually progress to a less cel-
lular stage characterized by increasing PG accumulation.
Characteristically, no inflammatory or fibrotic changes
accompanied these deposits or proliferative lesions. We
hypothesize that the proliferating fibroblasts secrete PGs
which then accumulate in tissues. The stimulus for the
proliferation of fibroblasts and the subsequent produc-
tion of proteoglycans is unknown. The proliferation of
fibroblasts and growth of the exuberant connective tissue
may explain the presence of pain in the early stage of the
disease.
Though flexor tendon microinjuries and subsequent his-
tological lesions can be found in virtually all horses, the
tendon lesions in horses afflicted with DSLD differed sig-
nificantly from "control" horses. All 28 horses with DSLD
had histopathological lesions in all SDFTs, DDFTs and
SLs. It is of interest that in our study many control SDFTs
and DDFTs had signs of old microinjuries consisting
mostly of small foci of fibrosis, i.e., regular scar tissue and
small deposits of PGs in the midmetacarpal (and proxi-
mal) region. This is different from other studies claiming
the sparsity of injuries to DDFT in normal horses [21,22].
Electron micrographs of normal and DSLD-affected tendon Figure 4
Electron micrographs of normal and DSLD-affected 
tendon. A. A cross-section of normal tendon reveals that 
most collagen fibrils have fairly large diameters. B. A marked 
increase in small collagen fibrils was observed in cross-sec-
tions of DSLD-affected tendon.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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The lack of systemic involvement in control horses is also
indicative that they did not have DSLD.
It is not clear whether the changes observed in the blood
vessels and eyes progress over time and lead to clinical
manifestations. Several horse breeders brought to our
attention that they have encountered horses with a record
of clinically diagnosed DSLD dying suddenly without a
precipitating disease. Abnormalites in connective tissues
components of the aorta or major vessels may predispose
to rupture of aortic aneurysm and sudden death [23,24].
Further epidemiologic studies are necessary to determine
the clinical significance of these findings.
DSLD is thought to run in families and bears some simi-
larity to several hereditary diseases afflicting connective
and musculoskeletal tissues in people. The first is called
Marfan's syndrome, which affects joints, the aorta, heart
valves and eyes. Affected individuals are typically tall,
have heart and eye problems and frequently die of a cata-
strophic rupture of the aorta. The genetic and biochemical
defect of Marfan's syndrome is a mutation in the gene for
fibrillin-1, an extracellular matrix protein involved in
Sepharose CL-2B chromatography of PGs in extracts from normal and DSLD-affected tendons Figure 5
Sepharose CL-2B chromatography of PGs in extracts from normal and DSLD-affected tendons. Guanidium HCl 
extracts from midmetacarpal portions of SDFTs from 2 affected horses (no. 20 and 21, Table 1) and from one control horse 
(no. 1, Table 3) were separated on a molecular sieve Sepharose CL-2B column (1.3 × 110 cm, equilibrated and eluted in 4 M 
guanidine HCl) at 0.1 ml/min. The majority of PGs eluted in one wide peak (fractions 66–81).
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proper organization of fibrils [23]. Because fibrillin-1 reg-
ulated activation of transforming growth factor β is
impaired in Marfan's patients and fibrillin deficient mice,
it is quite likely that accumulation of proteoglycans caus-
ing the prolapse of mitral valve, a prominent feature in
Marfan's syndrome, is one of the consequences [24].
Whether secondary changes in regulation of growth fac-
tors and other mediators play a role in DSLD is not known
at the present time. Elastic fragmentation and cystic
changes can be found in Marfan's syndrome and Erd-
heims' cystic medionecrosis [25] (and also in DSLD). In
addition the EM findings of small vacuoles in the cyto-
plasm of smooth muscle cells in the media from DSLD
aorta and of thinner and discontinuous membrane of
these cells appeared to be similar to ultrastructural
changes observed in endothelial cells in aortas from
patients with Marfan's syndrome and Erdheim's disease
and are indicative of increased cell permeability [26].
The second human disorder or group of related disorders
is Ehlers-Danlos syndrome. People with this disorder
experience increased fragility of the skin and hyperflexibil-
ity of the joints. The skin may be very loose, forming folds,
and prone to scarring. Because Ehlers-Danlos syndrome
comprises a group of clinically similar diseases rather than
one defined entity, its pathogenesis is more complicated.
It is likely that different mutations lead to different forms
of Ehlers-Danlos syndrome [27]. Mutation in the gene
encoding type III collagen leads to the most severe form of
Ehlers-Danlos syndrome, type IV [28]. Patients with this
form often develop and die of rupture of large blood ves-
sels, uterus or intestines [29,30].
The third, called Williams syndrome is characterized by
distinctive facial features, mental retardation, and cardio-
vascular disease. Sudden death often in young people is
associated with stenoses and other abnormalities of coro-
nary arteries [31]. Other cardiovascular malformations
include aortic stenosis and arch hypoplasia [32]. The
underlying defect is a mutation in the gene encoding for
elastin (ELN) [33]. The fourth entity, Caffey syndrome or
infantile cortical hyperostosis is characterized by subperi-
osteal bone formation, some Ehlers-Danlos features (e.g.,
joint hyperlaxity and hyperextensible skin), but also by a
localized inflammatory response. The symptoms are
attributed to a mutation in the gene encoding the α1(I)
chain of type I collagen (COL1A1) [34]. It is interesting to
note that some DSLD horses or their offspring develop
osteopetrosis (David Burrell, personal communication).
As far as we know none of these human hereditary disor-
ders is known to be caused by a defect in proteoglycan
biochemistry or genetics, thus making it different from
DSLD. However, because all mutations occur in genes
encoding for structural components of tendons and blood
vessel walls (e.g., collagen, elastin, fibrillin) that contrib-
ute to biomechanical integrity of these tissues, the dis-
eases share certain similarities in their presentation.
Current experiments in our laboratory are directed at the
characterization and identification of the specific prote-
oglycans involved in DSLD. Further characterization and
understanding of the pathogenesis of DSLD will allow us
develop diagnostic tests to identify asymptomatic horses
and help prevent the propagation of the syndrome
through a selective breeding program.
Conclusion
The findings of this study demonstrate that so called
degenerative suspensory ligament desmitis (DSLD)
thought to be limited to suspensory apparatus is actually
a systemic disorder affecting tissues with a high content of
connective tissue, such as tendons and other ligaments,
blood vessels and sclerae. Initial investigations suggest
that accumulation of still to be identified proteoglycans
between collagen and elastic fibers and around small
blood vessels is the underlying pathology. Due to the sys-
temic nature of the disease we feel that the term equine
systemic proteoglycan accumulation or ESPA is more
appropriate than DSLD.
SDS-PAGE of Sepharose CL-2B peaks Figure 6
SDS-PAGE of Sepharose CL-2B peaks. Aliquots of 
pooled Sepharose CL-2B fractions were precipitated with 
100% ethanol, dissolved in 15 µl of 100 mM Tris buffer, 
adjusted to pH 8.0 with concentrated acetic acid and 
digested with 20 mU of chondroitinase ABC at 37°C for 24 
h. Chondroitinase ABC digested samples and non-digested 
replicate aliquots were separated on silver stained 10% SDS-
polyacrylamide gels. Lane 1: untreated sample from control 
SDFT no. 1; lane 2: untreated sample from DSLD SDFT no.8 
(Table 1); lane 3: chondroitinase ABC treated sample from 
control SDFT no. 1; lane 4: chondroitinase ABC treated sam-
ple from SDFT no. 8 (Table 1).BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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Histopathological changes in arteries Figure 7
Histopathological changes in arteries. A. The media of normal aortic arch shows orderly aligned elastic fibers and very lit-
tle PGs between them. Hematoxylin & eosin, magnification × 200. B. Small pools of PGs (Ј) separate fibers and cells in the 
media of DSLD-affected aortic arch. Hematoxylin & eosin, magnification × 200. C. Alcian blue stains material aligned closely 
with elastic fibers in normal arch, magnification × 200. D. Pools of PGs (Ј) stain strongly with alcian blue in the media of 
DSLD-affected arch, magnification × 200. E. The media of normal coronary artery shows orderly aligned elastic fibers sepa-
rated by thin layers of PGs (Ј) between them. Hematoxylin & eosin, magnification × 200 (× 200). F. Small pools of PGs (Ј) 
separate fibers and cells in the media of DSLD-affected coronary artery. Hematoxylin & eosin, magnification × 200. G. Alcian 
blue stains material aligned closely with elastic fibers in the media of normal coronary artery, magnification × 100. H. Pools of 
PGs (Ј) stain strongly with alcian blue in the media of DSLD-affected coronary artery, magnification × 100.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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Methods
Cases and tissue collection
All horses were donated for research to the College of Vet-
erinary Medicine, The University of Georgia, Athens, GA.
All procedures were approved by the Animal Care and Use
Committee, University of Georgia, IACUC# A2001-
Ultrastructural features of normal and DSLD-affected aorta Figure 8
Ultrastructural features of normal and DSLD-affected aorta. A. Normal smooth muscle cell from media from a 
healthy aorta. B. A smooth muscle cell from the media of DSLD-affected aorta reveals the presence of numerous cytoplasmic 
vacuoles (*). C. normal smooth muscle cell has a well defined cell membrane (Ј). D. The cell membrane of a diseased media is 
disrupted and missing in places (Ј). E and F. Organization of collagen fibrils and elastic fibers is similar in normal (E) and DSLD 
aorta (F). SMC: smooth muscle cell, EL: elastic lamina, C: collagen fibrils.BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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10120). Twenty-eight horses clinically diagnosed with
DSLD (22 Peruvian Paso horses and 6 horses of other
breeds) were compared to 8 horses donated for reasons
other than lameness (control group) using light and elec-
tron microscopy, and gel chromatography. Postmortem
examination was conducted immediately following
euthanasia and tissues of interest were either processed for
histopathological and electron microscopy studies, or fro-
zen at -20°C until used for biochemical analysis. Superfi-
cial and deep digital flexor tendons and suspensory
ligaments were removed proximally at the level of the
proximal third metacarpus (= proximal portion) to the
level of the metacarpophalangeal joint above the fetlock
(or above the bifurcation of the SL, labeled by us as the
midmetacarpal portion). One section from the proximal
end and another section from the midmetacarpal end
were taken for histological examination. In many horses
the following tissues were examined for histopathology:
eyes, proximal portion of the right coronary artery, arch
and/or thoracic aorta, nuchal and patellar ligaments,
lung, skin, muscle and kidney.
Histopathology and immunohistochemistry
Five  µm thick sections from formalin fixed, paraffin
embedded tissues were stained with hematoxylin & eosin,
and with alcian blue (pH 2.5 and pH 1.0).
The core proteins of decorin and biglycan were identified
with rabbit polyclonal antibodies LF-30 or LF-136 to
decorin and LF-106 to biglycan (generous gift from Dr.
Larry Fisher, NIDCR, NIH [35]. The antibody to the core
protein of human aggrecan was a generous gift from Dr.
Peter Roughley [36]. We used an immunohistochemistry
protocol used by us previously [37]. Briefly, after depar-
affinization and rehydration in descending grades of ethyl
alcohol, tissue sections were quenched in 0.3% H2O2 in
methanol and non-specific sites were blocked with nor-
mal goat serum (Vector laboratories Inc., USA) for 30
minutes. Slides were incubated at 4°C overnight with pri-
mary antibodies (1:500 in PBS) to decorin, aggrecan or
biglycan. Next day, slides were treated with biotinylated
anti-rabbit IgG (H+L) secondary antibody, made in goat
(Vector Laboratories Inc.) at dilution 1:1000 in PBS for
one hour. Antigen-antibody complexes were detected
using an avidin-biotin complex detection system
(Vectastain Elite ABC Kit, Vector Laboratories, Burlin-
game, CA). Slides were stained with DAB Substrate kit
(Vector laboratories), rinsed in water and briefly counter
stained with hematoxylin and washed in water.
Electron microscopy
Samples of midmetacarpal regions of SDFTs from a
DLSD-affected (horse no. 8, Table 1) and a control (horse
no. 1, Table 3), and upper thoracic aorta from a control
horse (no. 1, Table 3) and thoracic aorta of two DSLD-
affected horse (case no. 9, 11, Table 1) were fixed at 4°C
in 2% glutaraldehyde/2% (para)formaldehyde/0.2% pic-
ric acid/0.1 M cacodylate buffer, pH 7.2. The fixed tissue
was rinsed at 4°C in 0.1 M cacodylate buffer/300 mM
sucrose, pH 7.2. Secondary fixation was performed for 1
hr at 4°C in 1% OsO4/0.1 M cacodylate buffer, pH 7.2.
After dehydration in solutions of increasing ethanol con-
centration the fixed aortic tissues were infiltrated with
propylene oxide and propylene oxide/Epon 812 mixture,
and embedded in Epon 812. Sections were positioned on
400 mesh grid, stained with uranyl acetate and lead cit-
rate, and examined using JEOL 100CXII Transmission
Electron Microscope.
The dehydrated fixed tendon tissues were infiltrated with
acetone/Spurr resine mixtures (50% Spurr for 1 hr, 50 %
Spurr overnight, and 100% Spurr twice for 1 hr. The ten-
don blocks were polymerized for 1 day at 60°C and were
sectioned with glass knives on a Leica Reichert Ultrami-
crotome. Sections were positioned on 400 mesh grids,
stained with uranyl acetate and lead citrate, and examined
using JEOL JEM-1210 Transmission Electron Microscope.
Proteoglycan extraction
Midmetacarpal portions of SDFTs from 2 affected horses
(no. 4 and 8, Table 1) and from one control horse (no. 1,
Table 3) were dissected, minced, defatted with a chloro-
form:methanol solution (1:1, 6 ml/1.0 g of dry weight
sample), and dried using a Speedvac (SVC 100 H; Thermo
Savant, Holbrook, NY). The dry tissue was homogenized
and extracted twice with 10 volumes of 4 M guanidine
HCl extraction buffer for 24 h on a rotator at 4°C as
described by us previously [18]. The combined extracts
were dialyzed against deionized water three times for 24 h
at 4°C.
Sepharose CL-2B chromatography
Dialyzed extracts were lyophilized and dissolved in 3 ml
of 4 M guanidine HCl. Two ml of dissolved sample (at
protein concentrations 4.4 mg/ml for horse no. 8 and
5.75 mg/ml for the control horse) were separated on a
molecular sieve Sepharose CL-2B column (1.25 × 110 cm,
equilibrated and eluted in 4 M guanidine HCl) at 0.1 ml/
min [18]. The Vt or total volume of the column was 146
ml and the Vo or void volume was 52 ml as determined
by Dextran blue elution.
SDS-PAGE
Aliquots (30 µg) of Sepharose CL-2B pools were precipi-
tated for 2 hrs at -80°C with 8 volumes of 100% ethanol.
The precipitates was dissolved in 15 µl of 100 mM Tris
buffer, adjusted to pH 8.0 with concentrated acetic acid
and digested with 20 mU of chondroitinase ABC (Proteus
vulgaris, Sigma, St. Louis, MO) at 37°C for 24 h. Chon-
droitinase ABC digested samples and non-digested repli-BMC Veterinary Research 2006, 2:12 http://www.biomedcentral.com/1746-6148/2/12
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cate aliquots were separated on 10% SDS-polyacrylamide
gels. The gels were stained with silver nitrate [38].
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